Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Prevention of Complications of Thalassemia, Request for Applications (RFA) DD07-010 and RFA DD07-011, 34467 [E7-12097]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 120 / Friday, June 22, 2007 / Notices
rwilkins on PROD1PC63 with NOTICES
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than July 19, 2007.
A. Federal Reserve Bank of St. Louis
(Glenda Wilson, Community Affairs
Officer) 411 Locust Street, St. Louis,
Missouri 63166-2034:
1. First Horizon National Corporation,
Memphis, Tennessee; to acquire 100
percent of Centerville State Bank,
Centerville, Kansas.
B. Federal Reserve Bank of Dallas
(W. Arthur Tribble, Vice President) 2200
North Pearl Street, Dallas, Texas 752012272:
1. BOC Holdings Corp., Fort Worth,
Texas; to become a bank holding
company by acquiring 100 percent of
the voting shares of Crowley Holding
Company, and thereby indirectly
acquire The Bank of Crowley, both of
Crowley, Texas.
2. Southside Bancshares, Inc., Tyler,
Texas; to acquire by merger 100 percent
of the voting shares of Fort Worth
Bancshares, Inc., and thereby indirectly
acquire voting shares of Fort Worth
National Bank, both of Fort Worth,
Texas.
Board of Governors of the Federal Reserve
System, June 19, 2007.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E7–12103 Filed 6–21–07; 8:45 am]
BILLING CODE 6210–01–S
VerDate Aug<31>2005
16:51 Jun 21, 2007
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Prevention of
Complications of Thalassemia,
Request for Applications (RFA) DD07–
010 and RFA DD07–011
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned SEP:
Time and Date: 1 p.m.–4 p.m., July 19,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of scientific merit of grant
applications received in response to RFA’s
DD07–010 and DD07–011, ‘‘Prevention of
Complications of Thalassemia.’’
Contact Person for More Information:
Juliana Cyril, Ph.D., Scientific Review
Administrator, Centers for Disease Control
and Prevention, 1600 Clifton Road, NE.,
Mailstop D72, Atlanta, GA 30333, Telephone
404.639.4639.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 13, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–12097 Filed 6–21–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10047]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
AGENCY:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
34467
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Physicians’
Referrals to Health Care Entities With
Which They Have Financial
Relationships and Supporting
Regulations in 42 CFR, 411.352 through
411.361; Use: The collection of
information contained in 42 CFR
411.352(d), 411.354(d), 411.355(e),
411.357(a), (b), (d), (e), (h), (l), (p), and
(s), and 411.361 is necessary to allow
CMS to implement section 1877 of the
Social Security Act. CMS issued these
regulations to comply with the
provisions of section 1877 of the Social
Security Act that prohibit a physician
from referring a patient to an entity for
a designated health service for which
Medicare might otherwise pay, if the
physician or an immediate family
member has a financial relationship
with the entity, unless an exception
applies. Form Number: CMS–10047
(OMB#: 0938–0846); Frequency: Yearly;
Affected Public: Business or other forprofit and Not-for-profit institutions;
Number of Respondents: 773,608; Total
Annual Responses: 773,608; Total
Annual Hours: 219,322.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or
e-mail your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received at the address below, no
later than 5 p.m. on August 21, 2007.
E:\FR\FM\22JNN1.SGM
22JNN1
]]>Agencies
[Federal Register Volume 72, Number 120 (Friday, June 22, 2007)]
[Notices]
[Page 34467]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-12097]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Prevention of Complications of Thalassemia,
Request for Applications (RFA) DD07-010 and RFA DD07-011
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
SEP:
Time and Date: 1 p.m.-4 p.m., July 19, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of scientific merit of grant applications
received in response to RFA's DD07-010 and DD07-011, ``Prevention of
Complications of Thalassemia.''
Contact Person for More Information: Juliana Cyril, Ph.D.,
Scientific Review Administrator, Centers for Disease Control and
Prevention, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333,
Telephone 404.639.4639.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: June 13, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-12097 Filed 6-21-07; 8:45 am]
BILLING CODE 4163-18-P
